Androvia LifeSciences is a biotechnology company focused on solving male fertility issues.
Androvia LifeSciences is among only a few companies in the world researching male fertility today. Powered by Dr. Alex Travis’ groundbreaking discoveries on the physiology of sperm, Androvia is focused on empowering men with the information to help them find potential fertility solutions.
There have been very few clinically significant advances in determining the cause of male fertility in the last two decades. Androvia was founded to change that.
Androvia has developed a novel, proprietary biomarker-based assay that assesses the functional ability of sperm to fertilize an egg. While other male fertility tests determine sperm count, motility and appearance, we believe Androvia’s test is the only test capable of helping to determine if the sperm is able to fertilize an egg. Specifically, this laboratory-developed test evaluates capacitation, the physiological cascade undergone by sperm in the female reproductive tract that enables the sperm to fertilize an egg.
Androvia’s cutting-edge technology, the Cap-Score™ Assay, is designed to help couples make informed decisions about their fertility.